1. Market Research
  2. > Business Services
  3. > Research and Development Market Trends
  4. > Genfit SA - Product Pipeline Review - 2015

Genfit SA - Product Pipeline Review - 2015

  • August 2015
  • -
  • Global Markets Direct
  • -
  • 38 pages

Genfit SA - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘Genfit SA - Product Pipeline Review - 2015’, provides an overview of the Genfit SA’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Genfit SA’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Genfit SA including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Genfit SA’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Genfit SA’s pipeline products

Reasons to buy

- Evaluate Genfit SA’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Genfit SA in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Genfit SA’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Genfit SA and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Genfit SA
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Genfit SA and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

Table Of Contents

Genfit SA - Product Pipeline Review - 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Genfit SA Snapshot 5
Genfit SA Overview 5
Key Information 5
Key Facts 5
Genfit SA - Research and Development Overview 6
Key Therapeutic Areas 6
Genfit SA - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Genfit SA - Pipeline Products Glance 11
Genfit SA - Clinical Stage Pipeline Products 11
Phase II Products/Combination Treatment Modalities 11
Phase I Products/Combination Treatment Modalities 12
Genfit SA - Early Stage Pipeline Products 13
Preclinical Products/Combination Treatment Modalities 13
Discovery Products/Combination Treatment Modalities 14
Genfit SA - Drug Profiles 15
elafibranor 15
Product Description 15
Mechanism of Action 15
RandD Progress 15
SAN/GFT-2 Program 18
Product Description 18
Mechanism of Action 18
RandD Progress 18
TGFTX-3 Program 19
Product Description 19
Mechanism of Action 19
RandD Progress 19
SERX-1 20
Product Description 20
Mechanism of Action 20
RandD Progress 20
TGFTX-1 Program 21
Product Description 21
Mechanism of Action 21
RandD Progress 21
TGFTX-4 Program 22
Product Description 22
Mechanism of Action 22
RandD Progress 22
TGFTX-5 Program 23
Product Description 23
Mechanism of Action 23
RandD Progress 23
Genfit SA - Pipeline Analysis 24
Genfit SA - Pipeline Products by Target 24
Genfit SA - Pipeline Products by Route of Administration 25
Genfit SA - Pipeline Products by Molecule Type 26
Genfit SA - Pipeline Products by Mechanism of Action 27
Genfit SA - Recent Pipeline Updates 28
Genfit SA - Dormant Projects 34
Genfit SA - Discontinued Pipeline Products 35
Discontinued Pipeline Product Profiles 35
AVE-0847 35
AVE-8134 35
GFT-14 35
Genfit SA - Locations And Subsidiaries 36
Head Office 36
Other Locations and Subsidiaries 36
Appendix 37
Methodology 37
Coverage 37
Secondary Research 37
Primary Research 37
Expert Panel Validation 37
Contact Us 37
Disclaimer 38

List of Tables
Genfit SA, Key Information 5
Genfit SA, Key Facts 5
Genfit SA - Pipeline by Indication, 2015 7
Genfit SA - Pipeline by Stage of Development, 2015 9
Genfit SA - Monotherapy Products in Pipeline, 2015 10
Genfit SA - Phase II, 2015 11
Genfit SA - Phase I, 2015 12
Genfit SA - Preclinical, 2015 13
Genfit SA - Discovery, 2015 14
Genfit SA - Pipeline by Target, 2015 24
Genfit SA - Pipeline by Route of Administration, 2015 25
Genfit SA - Pipeline by Molecule Type, 2015 26
Genfit SA - Pipeline Products by Mechanism of Action, 2015 27
Genfit SA - Recent Pipeline Updates, 2015 28
Genfit SA - Dormant Developmental Projects,2015 34
Genfit SA - Discontinued Pipeline Products, 2015 35
Genfit SA, Subsidiaries 36

List of Figures
Genfit SA - Pipeline by Top 10 Indication, 2015 7
Genfit SA - Pipeline by Stage of Development, 2015 9
Genfit SA - Monotherapy Products in Pipeline, 2015 10
Genfit SA - Pipeline by Top 10 Target, 2015 24
Genfit SA - Pipeline by Top 10 Route of Administration, 2015 25
Genfit SA - Pipeline by Top 10 Molecule Type, 2015 26
Genfit SA - Pipeline Products by Top 10 Mechanism of Action, 2015 27

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
ADC Therapeutics SA - Product Pipeline Review - 2016

ADC Therapeutics SA - Product Pipeline Review - 2016

  • $ 1500
  • Company report
  • November 2016
  • by Global Markets Direct

ADC Therapeutics SA - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘ADC Therapeutics SA - Product Pipeline Review - 2016’, provides an overview of the ADC Therapeutics SA’s pharmaceutical ...

PharmAbcine Inc - Product Pipeline Review - 2016

PharmAbcine Inc - Product Pipeline Review - 2016

  • $ 1500
  • Company report
  • December 2016
  • by Global Markets Direct

PharmAbcine Inc - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘PharmAbcine Inc - Product Pipeline Review - 2016’, provides an overview of the PharmAbcine Inc’s pharmaceutical ...

Janssen Research & Development LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Janssen Research & Development LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2016
  • by Global Data

Summary Janssen Research & Development LLC (Janssen), formerly Johnson & Johnson Pharmaceutical Research & Development, L.L.C., a subsidiary of Johnson & Johnson is a pharmaceutical company that offers ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.